Elizabeth Smyth
| Consultant Medical Oncologist & GI Oncology Lead, Oxford University Hospitals NHS Foundation Trust, UK Elected ESMO Director of Education (from 2025) Chair, ESMO Guidelines Committee | Chair, EORTC GI Trials Group (2024–2027) Clinical Lead, Oxford Clinical Trials Office (OCTO), University of Oxford |
| Dr. Elizabeth Smyth is a Consultant Medical Oncologist and GI Oncology Lead at Oxford University Hospitals NHS Foundation Trust, specialising in oesophagogastric cancer. In August 2025 she was elected ESMO Director of Education, responsible for shaping ESMO’s global oncology education programmes. She also serves as Chair of the ESMO Guidelines Committee, Chair of the EORTC GI Trials Group (2024–2027), and Clinical Lead at the Oxford Clinical Trials Office (OCTO), where she supports the development and governance of academic oncology trials. She trained in Dublin, New York (Memorial Sloan Kettering), and London (Royal Marsden), and holds an MD(Res) from the Institute of Cancer Research. She has published more than 200 peer-reviewed manuscripts — with over 23,000 citations — was subject editor for the ESMO Gastric and Oesophageal Cancer Guidelines, and is a founding member and trustee of the UK & Ireland Oesophagogastric Cancer Group (UKIOG, 2022). |